Gilead Donates $20 Million to Enhance Access to Treatment for Often Fatal Neglected Tropical Disease
FOSTER CITY, Calif., September 27, 2016 /3BL Media/ - Gilead Sciences, Inc. (Nasdaq: GILD) today announced it has entered into a partnership with the World Health Organization (WHO) to provide $20 million in funding and drug donations over five years to expand access to diagnostic services and treatment for visceral leishmaniasis (VL). As part of this collaboration, Gilead will donate 380,000 vials of AmBisome® (amphotericin B liposome for injection) to meet the needs of WHO to treat VL in key endemic countries, including Bangladesh, Ethiopia, India, Nepal, South Sudan and Sudan.
According to the World Health Organization, air pollution has increased by 8% in the past five years, with cities as the main culprit.
Over half of the global population live in cities, which means that billions of people around the world are now exposed to dangerous levels of air quality, according to data collected from over 3,000 cities by the World Health Organization (WHO). While cities across the globe are becoming increasingly polluted, WHO’s data indicates that those in the Middle East, south-east Asia and the western Pacific are the most impacted. Pollution levels in cities in those areas are 5-10 times above recommended levels.
- Building on the company's successful history in developing vaccines against similar viruses, most recently the introduction of Dengvaxia® against dengue, Sanofi Pasteur is launching a Zika vaccine project -
LYON, France, March 10, 2016 /3BL Media/ - Sanofi Pasteur, the vaccines division of Sanofi, announced today that it has launched a vaccine research and development project targeting the prevention of Zika virus infection and disease.
GAITHERSBURG, Md., October 29, 2015 /3BL Media/ - Sodexo, a leading provider of integrated facilities management and food service operations, announced a partnership today with SureWash, maker of a mobile, automated, interactive hand hygiene training and assessment system.
U.S. Patent and Trademark Office Honors Sanofi for its Anti-Malarial Treatment
BRIDGEWATER, NJ, April 15, 2015 /3BL Media/ – Sanofi announced today that the U.S. Commerce Department’s United States Patent and Trademark Office (USPTO) named the company one of 10 recipients of its prestigious “Patent for Humanity” award. Sanofi is being recognized for its patent that covers an innovative chemical and industrial process for producing semi-synthetic artemisinin utilized in the production of anti-malarial artemisinin-based combination therapies.
Argues that food safety is pivotal to the provision of sufficient amounts of safe, nutritious food
ROME, Italy, December 15, 2014 /3BL Media/ – Dave Crean, Mars, Incorporated’s Vice President of Corporate Research and Development attended the Second International Conference on Nutrition (ICN2) highlighting the scale of food safety issues across the globe, the role of food safety in providing global access to sufficient amounts of safe, nutritious food, and how industry leadership and collaboration can help tackle global malnutrition.
Children International Provides Services Focused on Helping Children and Youth Become Healthy, Educated and Self-Reliant Adults, and Maintaining Good Mental Health Is an Important Component
The World Health Organization (WHO) estimates about 450 million people worldwide suffer from a mental health disorder, and about three-fourths of that population live in developing countries with little or no access to treatment1. The United Nations has chosen the theme “Youth and Mental Health” for this year’s International Youth Day, which will be recognized on August 12.
Today's guest blog comes from Lilly's Vice President of Global Health Programs and Access, Dr. Evan Lee.
In an encouraging move, the World Health Assembly has passed a formal, long-term resolution to stop TB. This means that all countries that participate in the World Health Organization have agreed to a concrete strategy – with clear targets – that could potentially rid the world of this dreadful disease.
What would happen if you got an infection and there was no effective antibiotic available to treat it?The World Health Organization (WHO) says this is no longer a “what if” scenario, it’s already happening in every region of the world.
As the enrollment deadline at the end of this month for the Affordable Care Act draws near, the facts, figures, and comments from all sides are flying throughout the media sphere. It might be exactly the moment to look again at the big picture of U.S. health care as measured against that of the rest of the world, and remember why radical reform of the American health system was thought to be urgent in the first place.